2 terminated, 1 withdrawn. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Stage II Ovarian Germ Cell Tumor: new trials by email Literature Review of Stage II Ovarian Germ Cell Tumor trials Research Report on Stage II Ovarian Germ Cell Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant management of therapy complications, musculoskeletal complications management/prevention - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Not applicable | Withdrawn | Roswell Park Cancer Institute | 2012-05-01 | 2012-07-09 | |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer EF5, motexafin lutetium, pharmacological study - Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix | Not applicable | Terminated | National Cancer Institute (NCI) | 30 | 2004-05-01 | 2013-01-16 |
| Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer imatinib mesylate, therapeutic conventional surgery, laboratory biomarker analysis - Ovarian Dysgerminoma, Recurrent Malignant Testicular Germ Cell Tumor | Phase 2 | Terminated | National Cancer Institute (NCI) | 32 | 2002-06-01 | 2013-01-17 |
Carcinoma, Ovarian Epithelial (2) · Testicular Neoplasms (2) · Appendiceal Neoplasms (1) · Bile Duct Neoplasms (1) · Blast Crisis (1) · Breast Neoplasms (1) · Burkitt Lymphoma (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Congenital Abnormalities (1) · Dysgerminoma (1) · Fallopian Tube Neoplasms (1) · Gallbladder Neoplasms (1) · Gastrointestinal Stromal Tumors (1)
Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Genital Diseases (3) · Gonadal Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Adnexal Diseases (2) · Carcinoma (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases, Female (2) · Genital Diseases, Male (2)
Imatinib Mesylate (1) · Therapeutics (1) · motexafin lutetium (1)
National Cancer Institute (NCI) (2) · Roswell Park Cancer Institute (1)
United States (2)
Christopher Ryan (1) · Philip McCarthy (1) · Stephen Michael Hahn (1)
P01CA087971 (1), U10CA031946 (1)